As a disease that is best detected and treated early after onset, Alzheimer disease is characterized by a variety of aberrantly regulated proteins and molecules, which once identified can be used as biomarkers for disease and integrated into Alzheimer’s diagnostic tests. New research at the University of Illinois at Chicago by co-authors Dr.
News
A recent communication from the University of Texas at Arlington reported that computer scientists led by Professor Heng Huang won a $2 million grant funded by the National Institutes of Health to investigate the possibility of predicting whether a person is predisposed to develop Alzheimer’s disease by analyzing complex genomics data.
Collaboration for Alzheimer’s Prevention: An Initiative to Advance Alzheimer’s Disease Research
In a recent paper published in the Nature Reviews in Neurology journal, a team of US researchers discussed the current challenges, opportunities and emerging evaluation methods in preclinical Alzheimer disease treatments, describing a convergent initiative to improve Alzheimer disease prevention research coined as Collaboration…
In a recent study entitled “A Hot-Segment-Based Approach for the Design of Cross-Amyloid Interaction Surface Mimics as Inhibitors of Amyloid Self-Assembly” and published in Angewandte Chemie, a team of scientists…
Results from a recent study conducted by scientists at the Universidad Nacional Autónoma de México, Instituto Nacional de Pediatría, Centro Médico Cozumel Universities of Montana, Valle de México, Boise State and North Carolina, revealed that air pollution has a harmful effect on hippocampal metabolites as early neurodegeneration markers among young urbanites…
According to a new analysis conducted by Alzheimer’s Research UK one in three people born in 2015 will develop Alzheimer’s Disease (AD) during their lifetime. The results suggest an alarming crisis in national health as the population in the United Kingdom ages, and highlights the demand for global efforts to develop new successful…
In a newly published paper in Genes & Development journal entitled “Myxococcus CsgA, Drosophila Sniffer, and human HSD10 are cardiolipin phospholipases“, researchers from University of Georgia suggest that a soil bacterium protein named HSD10 reduces oxidative stress, stimulates repair of nerve cells and contributes to slow down…
Results from a recent study showed that women are more likely to not only be diagnosed with Alzheimer’s Disease (AD), but to also be more heavily burdened by the associated economic costs, compared to men. The study, entitled, “Gender Differences: A Lifetime Analysis of the Economic Burden of…
A recent study published this week in Nature has revealed that the “seeds” of Alzheimer’s disease and related brain disorders may be transmitted by direct tissue transplantation. The results from the study entitled “Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy”, coupled with…
Results from the largest nationwide study investigating long-term high-dose resveratrol in patients with mild to moderate Alzheimer’s disease (AD) showed that a specific a biomarker that declines with disease progression was stabilized in patients who received resveratrol in its purified form. The results, published online in Neurology,…
Recent Posts
- FDA approves Auvelity to treat Alzheimer’s-related agitation May 4, 2026
- Daily Alzheimer’s pill slows brain shrinkage, boosts cognition April 6, 2026
- Researchers explore surgical treatment’s potential in Alzheimer’s March 2, 2026
- FDA fast-tracks expanded home injections for Alzheimer’s drug Leqembi February 2, 2026
- FDA decision on AXS-05 for Alzheimer’s agitation expected April 30 January 6, 2026